Showing 4,921 - 4,940 results of 18,392 for search 'significantly ((((((we decrease) OR (a decrease))) OR (nn decrease))) OR (mean decrease))', query time: 0.75s Refine Results
  1. 4921
  2. 4922

    Flow chart of inclusion and exclusion criteria. by Ho Geol Woo (7180775)

    Published 2025
    “…Contrary to AD, treatment of VV group was significantly associated with decreased risk of VD (HR: 0.566, 95% CI: 0.382–0.841). …”
  3. 4923

    Baseline characteristics of study participants. by Ho Geol Woo (7180775)

    Published 2025
    “…Contrary to AD, treatment of VV group was significantly associated with decreased risk of VD (HR: 0.566, 95% CI: 0.382–0.841). …”
  4. 4924
  5. 4925

    Image2_Asymmetric dimethylarginine induces maladaptive function of the blood-brain barrier.TIF by Tetyana P. Buzhdygan (19822401)

    Published 2024
    “…We found that ADMA disrupted physical barrier function as evident by significant decrease in electrical resistance and increase in paracellular permeability of hBMVEC monolayers. …”
  6. 4926

    Image1_Asymmetric dimethylarginine induces maladaptive function of the blood-brain barrier.TIF by Tetyana P. Buzhdygan (19822401)

    Published 2024
    “…We found that ADMA disrupted physical barrier function as evident by significant decrease in electrical resistance and increase in paracellular permeability of hBMVEC monolayers. …”
  7. 4927
  8. 4928
  9. 4929
  10. 4930
  11. 4931
  12. 4932
  13. 4933
  14. 4934
  15. 4935
  16. 4936

    Connectivity maps and color maps of within-group analysis of the tDCS intervention. by Rael Lopes Alves (7877942)

    Published 2024
    “…(A) The maps demonstrate decreased connectivity between the left ACC and right INS in the HB-a-tDCS on DLPFC group in the delta frequency band in EO condition which present moderated effect size (Cohen’s d = 0.70). …”
  17. 4937
  18. 4938
  19. 4939

    Effect of ibuprofen (IBU) on COX-2 expression. by Katarina Grossmannova (7543517)

    Published 2025
    “…(C) Analysis of signaling pathways involved in COX-2 expression using specific inhibitors LY294002 (inhibiting PI3K/AKT pathway) and PD98059 (inhibiting ERK1/2 pathway) in hypoxic cell lines show that both pathways are involved in COX-2 expression in HCT116, RKO and UM-22A cells. In FaDu cells, only the ERK1/2 inhibitor decreased the level of IBU-mediated COX-2 expression.…”
  20. 4940